Dallen Medical
David H. Mills, President & CEO

Dallen Medical, Inc. is an early stage, venture backed orthopedic company whose patented technology will provide superior fixation and compression.  Dallen’s mission is to develop and commercialize its Compressyn technology to underserved markets to improve patient outcomes, resulting in cost savings and reductions in length of stay.

Currently, Dallen has FDA 510(K) clearance for its first product, the  Compressyn™  band and is well into the manufacturing validation process for a late year first-in-man study.  Dallen has also filed a 510(K) for its second product-line, the Compressyn™  staple,  offering superior fixation with compression for the small bone market.  Dallen’s banding and staple technology addresses almost a $1 billion market opportunity with multiple follow-on product(s) and applications.